全文获取类型
收费全文 | 1142篇 |
免费 | 133篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 86篇 |
妇产科学 | 20篇 |
基础医学 | 130篇 |
口腔科学 | 51篇 |
临床医学 | 131篇 |
内科学 | 252篇 |
皮肤病学 | 20篇 |
神经病学 | 41篇 |
特种医学 | 253篇 |
外科学 | 65篇 |
综合类 | 24篇 |
预防医学 | 99篇 |
眼科学 | 16篇 |
药学 | 72篇 |
中国医学 | 1篇 |
肿瘤学 | 41篇 |
出版年
2021年 | 8篇 |
2019年 | 9篇 |
2018年 | 16篇 |
2017年 | 11篇 |
2016年 | 7篇 |
2015年 | 16篇 |
2014年 | 18篇 |
2013年 | 18篇 |
2012年 | 8篇 |
2011年 | 23篇 |
2010年 | 37篇 |
2009年 | 26篇 |
2008年 | 19篇 |
2007年 | 41篇 |
2006年 | 36篇 |
2005年 | 31篇 |
2004年 | 16篇 |
2003年 | 37篇 |
2002年 | 21篇 |
2001年 | 35篇 |
2000年 | 27篇 |
1999年 | 30篇 |
1998年 | 64篇 |
1997年 | 78篇 |
1996年 | 82篇 |
1995年 | 51篇 |
1994年 | 39篇 |
1993年 | 46篇 |
1992年 | 29篇 |
1991年 | 18篇 |
1990年 | 23篇 |
1989年 | 48篇 |
1988年 | 46篇 |
1987年 | 37篇 |
1986年 | 39篇 |
1985年 | 35篇 |
1984年 | 11篇 |
1983年 | 14篇 |
1982年 | 16篇 |
1981年 | 15篇 |
1980年 | 14篇 |
1979年 | 8篇 |
1978年 | 7篇 |
1977年 | 16篇 |
1976年 | 10篇 |
1975年 | 15篇 |
1973年 | 6篇 |
1972年 | 6篇 |
1969年 | 5篇 |
1968年 | 6篇 |
排序方式: 共有1303条查询结果,搜索用时 15 毫秒
1.
Isolated patellofemoral arthritis is an increasingly recognized entity, and is usually associated with previous patellofemoral dysplasia or instability. Patellofemoral arthroplasty (PFA) has evolved significantly in recent years, both in terms of implant design and importantly in the understanding of appropriate patient selection. This review outlines the indications and investigations for PFA, provides a brief history of the development of contemporary implants, and presents the clinical outcomes for the prostheses most commonly used in the UK. In addition, it provides a detailed surgical technique for implantation of an onlay implant, with tips on how to optimize patellofemoral biomechanics and thus achieve a consistently good outcome. 相似文献
2.
3.
Sonoelasticity imaging of prostate cancer: in vitro results 总被引:2,自引:0,他引:2
4.
H. S. Markus A. M. Tomkins G. M. Stern 《Journal of neural transmission (Vienna, Austria : 1996)》1993,5(2):117-125
Summary An anthropometric study was performed in 95 subjects (53 male, 42 female) with Parkinson's disease. Weight, height, triceps and biceps skin-fold thicknesses, and mid-arm circumference were recorded. A high incidence of undernutrition was found (23.6% of males and 22.5% of females, as defined by recent British guidelines). A subgroup of severely disabled patients with Parkinson's disease had a significantly lower mean body mass index than a similarly disabled control group with chronic pyramidal upper motor neuron lesions (males 20.6v 23.2 kg/m2 p<0.05; females 20.6v 26.6 kg/m2 p<0.01), suggesting that the undernutrition is not due to chronic illness or immobility alone. Correlation between anthropometric indices and clinical features of disease demonstrated that the presence of moderate or severe dyskinetic movements was the clinical parameter most strongly related to undernutrition. The reduction in anthropometric indices was most marked for skin fold thickness (related to percentage body fat) and least for arm muscle circumference (related to lean body mass); therefore the weight loss seen in Parkinson's disease is primarily due to fat loss rather than muscle loss. 相似文献
5.
6.
Previous work has reported that the 5-hydroxytryptamine (5-HT)1A agonist, 8-hydroxy 2-(di-n-propylamino)tetralin (8-OH DPAT), reduces ethanol intake by rats. However, as 8-OH DPAT reduces 5-HT neurotransmission, these findings are inconsistent with the proposed inhibitory role of central 5-HT neurons on ethanol intake. We examined the effect of 8-OH DPAT on ethanol, water and food intake in rats maintained on a limited access schedule using a lower dose range (6–250 µg/kg) and by assessing concomitant changes in behaviour. Low doses of 8-OH DPAT enhanced ethanol intake even when food and water were offered as alternatives. Suppression in ethanol intake was observed at higher doses where elements of the 5-HT syndrome were apparent. Similar observations were made in both fluid and non-fluid deprived water drinking rats, suggesting the latter effect is non-selective. Therefore 8-OH DPAT may both increase or decrease ethanol consumption in the rat depending on the dose used. 相似文献
7.
8.
9.
10.
Ten thrombocytopenic patients (platelets < 10–24 × 10(9)/L) who were refractory to platelet transfusion were investigated for their responsiveness to staphylococcal protein A column therapy. Nine patients had previously been treated with steroids, intravenous immune globulin, and/or other forms of immunosuppressive therapy without improvement in their transfusion response. All patients were receiving multiple platelet transfusions without achieving 1-hour corrected count increments (CCIs) > or = 7500. Eight patients had antibodies that reacted with platelets and were directed against HLA class I antigens, ABO antigens, and/or platelet-specific alloantigens. Plasma (500-2000 mL) from each patient was passed over a protein A silica gel column and then returned to the patient. Patients received from 1 to 14 treatments. A positive response to protein A therapy was defined as at least a doubling of the pretreatment platelet count and/or two successive 10- to 120-minute posttransfusion CCIs > or = 7500. Following plasma treatments, 6 of 10 patients responded with daily platelet counts that averaged 48 +/− 11 × 10(9) per L as compared with counts of 16 +/− 7 × 10(9) per L (p < 0.0005) before treatment. Posttransfusion CCI values determined in four of these patients averaged 2480 +/− 810 and 10,010 +/− 3540 (p < 0.005) before and after treatment, respectively. In contrast, among the four unresponsive patients, platelet counts averaged 10 +/− 9 and 13 +/− 10 × 10(9) per L (p = NS), respectively, while posttransfusion CCIs were 700 +/− 1410 and 1520 +/− 2460 (p = NS), respectively.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献